Hypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway

Abstract

Endothelial lesion response to injurious stimuli is a necessary step for initiating inflammatory cascades in blood vessels. Hypaphorine (Hy) from different marine sources is shown to exhibit anti-inflammatory properties. However, the potential roles and possible molecular mechanisms of Hy in endothelial inflammation have yet to be fully clarified. We showed that Hy significantly inhibited the positive effects of lipopolysaccharide (LPS) on pro-inflammatory cytokines expressions, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), monocyte chemoattractant protein 1 (MCP-1) and vascular cellular adhesion molecule-1 (VCAM-1), as well as induction of the phosphorylation of Akt and mTOR in HMEC-1 cells. The downregulated peroxisome proliferator-activated receptor γ (PPAR-γ) and upregulated toll-like receptor 4 (TLR4) expressions in LPS-challenged endothelial cells were prevented by Hy. Inhibition of both PI3K and mTOR reversed LPS-stimulated increases in TLR4 expressions and decreases in PPAR-γ levels. Genetic silencing of TLR4 or PPAR-γ agonist pioglitazone obviously abrogated the levels of pro-inflammatory cytokines in LPS-treated HMEC-1 cells. These results suggest that Hy may exert anti-inflammatory actions through the regulation of TLR4 and PPAR-γ dependent on PI3K/Akt/mTOR signal pathways. Hy may be considered as a therapeutic agent that can potentially relieve or ameliorate endothelial inflammation-associated diseases.

Salusin‐β Is Involved in Diabetes Mellitus‐Induced Endothelial Dysfunction via Degradation of Peroxisome Proliferator‐Activated Receptor Gamma

“…ELISA assays were performed to measure salusin- β level in stimulated HUVECs according to the manufacturer's protocols (USCN Life Science, Houston, TX, USA). The protein levels of TNF- α , IL-1 β , VCAM-1, and MCP-1 in medium supernatant from each sample were detected by commercial ELISA kits (BOSTER, Wuhan, China) according to the manufacturer's instructions as previously described [ 36 , 37 ]. The blanks, diluted standards, or samples were added appropriately into coat wells in 96-well plates and HRP-conjugated antibody was coincubated at 37°C for 30 min.…”

Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression

“…TLR4 and TLR2 are widely expressed in melanoma cells 14 . To determine the necessity of TLR4 for LPS-and MPLAs-induced STAT3 activation, we knocked down TLR4 in A375 cells using a specific siRNA (siTLR4; 1555) that has been shown to be able to effectively silence TLR4 15 , and then stimulated the cells with TLR4 ligands. Efficient gene knockdown was confirmed by RT-qPCR ( Fig.…”

Epithelial Cells Attenuate Toll-Like Receptor-Mediated Inflammatory Responses in Monocyte-Derived Macrophage-Like Cells to Mycobacterium tuberculosis by Modulating the PI3K/Akt/mTOR Signaling Pathway

“…Intriguingly, the inhibition of PI3K, Akt, or mTOR activity led to a reduction of intracellular infection in mammary epithelial cancer MCF-7 cells to BCG, indicating a critical role of the PI3K/Akt/mTOR pathway in the immune response of mycobacterial infection [ 45 ]. Moreover, pharmacological inhibitions of PI3K/AKT/mTOR signaling led to a drastic reduction of the production of proinflammatory cytokines in monocytes and macrophages [ 46 ] and reversed the LPS-stimulated increase of TLR4 expression and decrease of the peroxisome proliferator-activated receptor gamma (PPAR-gamma) level in human endothelial cells [ 47 ]. Consistently, the inhibition of PI3K or mTOR with LY294002 or rapamycin (Rapa) led to a dramatically reduced expression of TLR signaling elements and cytokine production in U937 macrophage-like cells to Mtb infection in the present study.…”